Charles L. Daley

Also affiliated with University of Colorado Denver

MedicineVeterinary

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 28 papers. Top paper: “Early Therapy for Latent Tuberculosis Infection”.

Early Therapy for Latent Tuberculosis Infection

American Journal of Epidemiology(2001)10.1093/aje/153.4.381

N/A

7.0DataRank · unranked

129 citations

Charles L. Daley, Sally M. Blower, Elad Ziv

Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline

Clinical Infectious Diseases(2020)10.1093/cid/ciaa241

N/A

1.0DataRank · unranked

800 citations

Jonathan M. Iaccarino, Christoph Lange, Emmanuelle Cambau, Richard J. Wallace, C. Andréjak +16 more

Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1125

N/A

0.999DataRank · unranked

779 citations

Jonathan M. Iaccarino, Christoph Lange, Emmanuelle Cambau, Richard J. Wallace, C. Andréjak +16 more

Brensocatib in non-cystic fibrosis bronchiectasis: ASPEN protocol and baseline characteristics

ERJ Open Research(2024)10.1183/23120541.00151-2024

N/A

0.902DataRank · unranked

32 citations

Pierre-Régis Burgel, Charles L. Daley, Anthony De Soyza, Charles Haworth, David T. Mauger +6 more

Genomic characterization of sporadic isolates of the dominant clone of Mycobacterium abscessus subspecies massiliense

Scientific Reports(2021)10.1038/s41598-021-94789-y

N/A

0.891DataRank · unranked

25 citations

Jeanne Benoit, Sara M. Kammlade, Nabeeh A. Hasan, L. Elaine Epperson, Terry Smith +9 more

Patient-Reported Symptom and Health-Related Quality-of-Life Validation and Responsiveness During the First 6 Months of Treatment for Mycobacterium avium Complex Pulmonary Disease

CHEST Journal(2023)10.1016/j.chest.2023.02.015

N/A

0.788DataRank · unranked

19 citations

Alexandra L. Quittner, Nathan F. Dieckmann, Heather Franklin, Amanda E. Brunton, Charles L. Daley +56 more

Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline

American Journal of Respiratory and Critical Care Medicine(2024)10.1164/rccm.202410-2096st

N/A

0.742DataRank · unranked

140 citations

Raquel Duarte, Sonal S. Munsiff, Carla A. Winston, Manoj J. Mammen, Ibrahim Abubakar +23 more

Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex

Antimicrobial Agents and Chemotherapy(2018)10.1128/aac.01105-18

N/A

0.571DataRank · unranked

44 citations

Byung Woo Jhun, Su-Young Kim, Junsu Choe, Kyeongman Jeon, Hee Jae Huh +6 more

“One-Two Punch”: Synergistic ß-Lactam Combinations forMycobacterium abscessusand Target Redundancy in the Inhibition of Peptidoglycan Synthesis Enzymes

Clinical Infectious Diseases(2021)10.1093/cid/ciab535

N/A

0.557DataRank · unranked

40 citations

Khalid M Dousa, Sebastian G. Kurz, Sheldon T. Brown, George L. Drusano, Steven M. Holland +5 more

Long-term Safety and Tolerability of Omadacycline for the Treatment of Mycobacterium abscessus Infections

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad335

N/A

0.557DataRank · unranked

40 citations

Wendy Bullington, Paige E Faasuamalie, Adrah Levin, Gabriella Porter, Ryan Stadnik +8 more

Prospective evaluation of nontuberculous mycobacteria disease in cystic fibrosis: The design of the PREDICT study

Journal of Cystic Fibrosis(2023)10.1016/j.jcf.2023.08.007

N/A

0.488DataRank · unranked

6 citations

Silvia M. Caceres, Katie R. Poch, N. Rysavy, Valerie K. Lovell, Emily Armantrout +14 more

Pharmacokinetics of oral antimycobacterials and dosing guidance for Mycobacterium avium complex treatment in cystic fibrosis

Journal of Cystic Fibrosis(2021)10.1016/j.jcf.2021.04.011

N/A

0.486DataRank · unranked

10 citations

Brandie D. Wagner, Laney Brennan, Michael F. Wempe, Peter L. Anderson, Charles L. Daley +4 more

Preclinical murine models for the testing of antimicrobials against Mycobacterium abscessus pulmonary infections: Current practices and recommendations

Tuberculosis(2024)10.1016/j.tube.2024.102503

N/A

0.477DataRank · unranked

23 citations

Tracey L. Bonfield, Jim P. Boyce, Charles L. Daley, Thomas Dick, Mercedes Gonzalez‐Juarrero +10 more

Trial Conduct, Baseline Characteristics, and Symptom Burden of Patients in the ARISE Study

Pulmonary Therapy(2025)10.1007/s41030-025-00293-3

N/A

0.196DataRank · unranked

2 citations

James D. Chalmers, Patrick A. Flume, David E. Griffith, Naoki Hasegawa, Kozo Morimoto +10 more

Notes from the Field: Potential Outbreak of Extrapulmonary Mycobacterium abscessus subspecies massiliense Infections from Stem Cell Treatment Clinics in Mexico — Arizona and Colorado, 2022

MMWR Morbidity and Mortality Weekly Report(2024)10.15585/mmwr.mm7318a3

N/A

0.104DataRank · unranked

1 citations

Nabeeh A. Hasan, Vinicius Calado Nogueira de Moura, L. Elaine Epperson, Christopher A. Czaja, Helen Johnston +11 more

Synergistic effects of sulopenem in combination with cefuroxime or durlobactam against Mycobacterium abscessus

mBio(2024)10.1128/mbio.00609-24

N/A

0DataRank · unranked

20 citations

Eunjeong Shin, Sebastian G. Kurz, Mark S. Plummer, Mary Nantongo, Christopher R. Bethel +8 more

In vitro activity of cefoxitin, imipenem, meropenem, and ceftaroline in combination with vaborbactam against Mycobacterium abscessus

Antimicrobial Agents and Chemotherapy(2024)10.1128/aac.00174-24

N/A

0DataRank · unranked

5 citations

Elena Shashkina, Natalia Kurepina, Vinicius Calado Nogueira de Moura, Charles L. Daley, Barry N. Kreiswirth +1 more

Trial design of bacteriophage therapy for nontuberculous mycobacteria pulmonary disease in cystic fibrosis: The POSTSTAMP study

Journal of Cystic Fibrosis(2025)10.1016/j.jcf.2025.03.669

N/A

0DataRank · unranked

2 citations

Stacey L. Martiniano, Valerie K. Lovell, Brian Vestal, Katie R. Poch, Silvia M. Caceres +45 more

Genomic and epidemiologic investigation of Mycobacterium abscessus isolates in a cystic fibrosis center to determine potential routes of transmission

Journal of Cystic Fibrosis(2025)10.1016/j.jcf.2025.07.003

N/A

0DataRank · unranked

1 citations

Jason Fullmer, Gregory McCleland, Silvia M. Caceres, Katie R. Poch, Nabeeh A. Hasan +11 more

Management of Nontuberculous Mycobacterial Pulmonary Disease Refractory to Guideline-Based Therapy: A Systematic Review

medRxiv(2025)10.1101/2025.06.23.25330100

N/A

0DataRank · unranked

1 citations

Bianca C. Martins, Ana Aguiar, Marina Pinheiro, Onno W. Akkerman, Timothy R. Aksamit +15 more

Preclinical Evaluation of Inhalational Spectinamide-1599 Therapy against Tuberculosis

ACS Infectious Diseases(2021)10.1021/acsinfecdis.1c00213

N/A

0DataRank · unranked

27 citations

Pradeep B. Lukka, Santosh Wagh, Amanda Walz, Jennifer Arab, Camron Pearce +14 more

Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline

European Respiratory Journal(2020)10.1183/13993003.00535-2020

N/A

0DataRank · unranked

907 citations

Jonathan M. Iaccarino, Christoph Lange, Emmanuelle Cambau, Richard J. Wallace, C. Andréjak +16 more

Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infection

Cell(2022)10.1016/j.cell.2022.04.024

N/A

0DataRank · unranked

249 citations

Rebekah M. Dedrick, Alice Gray, Eszter K. Vladar, Bailey E. Smith, Krista G. Freeman +25 more

Nontuberculous Mycobacterial Infections in Cystic Fibrosis

Clinics in Chest Medicine(2022)10.1016/j.ccm.2022.06.010

N/A

0DataRank · unranked

36 citations

Jerry A. Nick, Charles L. Daley, Stacey L. Martiniano

Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease

Clinical Infectious Diseases(2023)10.1093/cid/ciad312

N/A

0DataRank · unranked

46 citations

Marcos C. Schechter, David Ashkin, Charles A. Peloquin, J. Peter Cegielski, Barbara B Andrino +95 more

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis

UNC Libraries(2020)10.17615/0e9w-2s88

N/A

0DataRank · unranked

0 citations

Diana Bilton, Bruce C. Marshall, Ronald L. Gibson, Charles Haworth, Kenneth N. Olivier +15 more

Development of Drugs for Nontuberculous Mycobacterial Disease

CHEST Journal(2020)10.1016/j.chest.2020.08.2055

N/A

0DataRank · unranked

26 citations

David E. Griffith, James D. Chalmers, Charles L. Daley, Kenneth N. Olivier, Anne O’Donnell +5 more

Airway Clearance Techniques in Bronchiectasis

CHEST Journal(2020)10.1016/j.chest.2020.06.050

N/A

0DataRank · unranked

49 citations

Radmila Choate, Doreen Addrizzo‐Harris, Timothy R. Aksamit, Alan R. Barker, Charles L. Daley +17 more